Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

248

HTML

2138

Figures (1-2)

189

Tables (1-3)

197

Sum=2772

Apr 14, 2005 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Apr 14, 2005; 11(14): 2162-2165
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2162

Table 2 Correlation between p53 and mdm2 expression and prognosis.

¹Group comparison was performed by log-rank test (χ² = 11, P = 0.012).

Citation: Dong M, Ma G, Tu W, Guo KJ, Tian YL, Dong YT. Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer. World J Gastroenterol 2005; 11(14): 2162-2165
URL: https://www.wjgnet.com/1007-9327/full/v11/i14/2162.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i14.2162